Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OraVescent Fentanyl for Breakthrough Pain in Non-Cancer Chronic Pain
NCT00343733Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Aug 2006; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00343733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343733.